Oprelvekin
Brand names,
Oprelvekin
Analogs
Oprelvekin
Brand Names Mixture
Oprelvekin
Chemical_Formula
C854H1411N253O235S2
Oprelvekin
RX_link
http://www.rxlist.com/cgi/generic3/oprelvek.htm
Oprelvekin
fda sheet
Oprelvekin
msds (material safety sheet)
Oprelvekin
Synthesis Reference
No information avaliable
Oprelvekin
Molecular Weight
19047.2
Oprelvekin
Melting Point
No information avaliable
Oprelvekin
H2O Solubility
No information avaliable
Oprelvekin
State
Liquid
Oprelvekin
LogP
-0.070
Oprelvekin
Dosage Forms
Powder for solution; Solution (subcutaneous injection)
Oprelvekin
Indication
Increases reduced platelet levels due to chemotherapy
Oprelvekin
Pharmacology
Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis
Oprelvekin
Absorption
No information avaliable
Oprelvekin
side effects and Toxicity
No information avaliable
Oprelvekin
Patient Information
No information avaliable
Oprelvekin
Organisms Affected
Humans and other mammals